Colorectal Cancer Screening - Medicare Advantage

Covers colorectal cancer screening in asymptomatic individuals, including endoscopic procedures (colonoscopy, sigmoidoscopy), stool and molecular tests (e.g., SEPT9), and adjunct visualization technologies (AI/CAD, G‑EYE, chromoendoscopy). Applicable to Medicare Advantage beneficiaries and other Medicare-covered populations per Medicare screening guidance. Coverage, frequency, age limits and specific test eligibility defer to applicable CMS NCDs/LCDs/LCAs (including MolDX LCDs for molecular tests), MAC jurisdiction and the member’s coverage document, and adjunct technologies are treated as add‑ons to endoscopy rather than standalone services.

"Reference to Colorectal Cancer coverage in the Medicare Benefit Policy Manual, Chapter 15, § 280."

Sign up to see full coverage criteria, indications, and limitations.